274 related articles for article (PubMed ID: 15478555)
1. [A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].
Firsova VA; Poluektova FG; Kuz'min AV; Chernousova LN
Probl Tuberk Bolezn Legk; 2004; (8):28-30. PubMed ID: 15478555
[TBL] [Abstract][Full Text] [Related]
2. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
[TBL] [Abstract][Full Text] [Related]
3. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
[TBL] [Abstract][Full Text] [Related]
4. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].
Isakova ZhT; Pak OA; Iusupova EIu; Myrzaliev BB; Chubakov TCh; Goncharova ZA; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Alisherov ASh; Friedland J; Aldashev AA
Probl Tuberk Bolezn Legk; 2005; (8):50-3. PubMed ID: 16209022
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
[TBL] [Abstract][Full Text] [Related]
6. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
7. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
8. [Direct genetic analysis of the rifampicin resistance of M. tuberculosis isolates in sputum samples].
Generozov EV; Akopian TA; Vladimirskiĭ MA; Shipina LK; Irtuganova OA; Govorun VM
Probl Tuberk Bolezn Legk; 2003; (4):49-52. PubMed ID: 12774423
[TBL] [Abstract][Full Text] [Related]
9. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Gubkina MF; Ershova NG
Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
[TBL] [Abstract][Full Text] [Related]
10. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.
Morcillo N; Zumarraga M; Alito A; Dolmann A; Schouls L; Cataldi A; Kremer K; van Soolingen D
Int J Tuberc Lung Dis; 2002 Nov; 6(11):959-65. PubMed ID: 12475141
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].
Vasil'eva IA; Chernousova LN; Zasedatelev AS; Sobolev AIu; Mikhaĭlovich VM
Probl Tuberk; 2002; (6):21-4. PubMed ID: 12227044
[TBL] [Abstract][Full Text] [Related]
12. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
Il'iuna TIa; Zhangireev AA; Sidorenko OA
Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Ani AE; Idoko J; Dalyop YB; Pitmang SL
Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
[TBL] [Abstract][Full Text] [Related]
14. [Determination of multidrug resistance of M. tuberculosis by different methods].
Poliakov AE; Safonova SG; Skotnikova OI
Probl Tuberk Bolezn Legk; 2006; (6):40-2. PubMed ID: 16881235
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary tuberculosis in adolescents in relation to different degree of drug resistance].
Firsova VA; Rusakova LI; Poluéktova FG; Iatskova TV; Ryzhova AP; Kobulashvili MG
Probl Tuberk; 2002; (12):23-5. PubMed ID: 12611330
[TBL] [Abstract][Full Text] [Related]
16. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
17. [Drug resistant tuberculosis in children and adolescents].
Aksenova VA; Luginova EF
Probl Tuberk; 2003; (1):25-8. PubMed ID: 12652979
[TBL] [Abstract][Full Text] [Related]
18. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
19. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
Kuz'min AV; Vasil'eva IA; Chernousova LN
Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
Talay F; Kumbetli S; Altin S
Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
